BD-AcAc2

• UNSPSC Description:

  BD-AcAc2 is an orally active antiepileptic. BD-AcAc2 results in body weight loss or maintenance with moderate increases in circulating ketones[1][2].

• Target Antigen:

  Others

• Type:

  Reference compound

• Related Pathways:

  Others

• Field of Research:

  Metabolic Disease; Cardiovascular Disease

• Assay Protocol:

  https://www.medchemexpress.com/bd-acac2.html

• Smiles:

  O=C(CC(C)=O)OCCC(C)OC(CC(C)=O)=O

• Molecular Weight:

  258.27

• References & Citations:

  [1]D'Agostino DP, et al. Therapeutic ketosis with ketone ester delays central nervous system oxygen toxicity seizures in rats. Am J Physiol Regul Integr Comp Physiol. 2013 May 15;304(10):R829-36. |[2]Roberts BM, et al. Effects of an exogenous ketone ester using multi-omics in skeletal muscle of aging C57BL/6J male mice. Front Nutr. 2022 Nov 15;9:1041026.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  58213-75-5